FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes
Circulation Research · 06.06.2025 · 136 (12) · 1545-1560
DOI: 10.1161/circresaha.124.325918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 06.06.2025. Verfasst von Kaitlyn M J H Dennis und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics (K.M.J.H.D., C.N.M.A., J.A.Z., M.C.-G., T.N., R.M.D., R.D.C., U.P., C.A.C., G.S., E.K.G., P.S., S.D.V.…. Hauptthemen laut MEDLINE: CD36 Antigens, Forkhead Box Protein O1, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Wellcome Trust, Dutch Research Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: The fatty acid (FA) transporter CD36 (FA translocase/cluster of differentiation 36) is the gatekeeper of cardiac FA metabolism. Preferential localisation of CD36 to the sarcolemma is one of the initiating cellular responses in the development of muscle insulin resistance and in the type 2 diabetic heart. Post-translational S-acylation controls protein trafficking, and in this study we hypothesised that increased CD36 S-acylation may underpin the preferential sarcolemmal localisation of CD36, driving metabolic and contractile dysfunction in diabetes. METHODS: Type 2 diabetes was induced in the rat using high fat diet and a low dose of streptozotocin. Forkhead box O1 (FoxO1) transcriptional regulation of zDHHC4 (zinc finger DHHC-type palmitoyltransferase 4) and subsequent S-acylation of CD36 was assessed using chromatin immunoprecipitation (ChIP) sequencing, ChIP-quantitative polymerase chain reaction, luciferase assays, siRNA (small interfering RNA) and shRNA silencing. RESULTS: Type 2 diabetes increased cardiac CD36 S-acylation, CD36 sarcolemmal localisation, FA oxidation rates and triglyceride storage in the diabetic heart. CD36 S-acylation was increased in diabetic rats, db/db mice, diabetic pigs and insulin-resistant human iPSC-derived cardiomyocytes, demonstrating conservation between species. The enzyme responsible for S-acylating CD36, zDHHC4, was transcriptionally upregulated in the diabetic heart, and genetic silencing of zDHHC4 decreased CD36 S-acylation. We identified that zDHHC4 expression is under the regulation of the transcription factor FoxO1. Diabetic mice with cardiomyocyte-specific FoxO1 deletion had decreased cardiac zDHHC4 expression and decreased CD36 S-acylation, which was further confirmed using diabetic mice treated with the FoxO1 inhibitor AS1842856. Pharmacological inhibition of zDHHC enzymes in diabetic hearts decreased CD36 S-acylation, sarcolemmal CD36 content, FA oxidation rates and triglyceride storage, culminating in improved cardiac function in diabetes. Conversely, inhibiting the de-acylating enzymes in control hearts increased CD36 S-acylation, sarcolemmal CD36 content and FA metabolic rates in control hearts, recapitulating the metabolic phenotype seen in diabetic hearts. CONCLUSIONS: Activation of the FoxO1-zDHHC4-CD36 S-acylation axis drives metabolic and contractile dysfunction in the type 2 diabetic heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy and Genetics (K.M.J.H.D., C.N.M.A., J.A.Z., M.C.-G., T.N., R.M.D., R.D.C., U.P., C.A.C., G.S., E.K.G., P.S., S.D.V., L.C.H.), University of Oxford, United Kingdom.
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada (K.G., J.R.U.).
- Department of Chemistry (R.M.D.), University of Oxford, United Kingdom.
- Department of Chemistry, University of Chicago, IL (S.-A.A., T.L., B.C.D.).
- Division of Experimental Cardiology, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, the Netherlands (O.S., I.H.A.H., D.J.D.).
- Turku PET Centre, University of Turku and Turku University Hospital, Finland (I.H.A.H.).
ORCID-Profile: Kaitlyn M J H Dennis, Keshav Gopal, Claudia N Montes Aparicio, Jiashuo Aaron Zhang, Marcos Castro-Guarda, Thomas Nicol, Ríona M Devereux, Saara-Anne Azizi, Tong Lan, Ujang Purnama, Carolyn A Carr, Gul Simsek, Pawel Swietach, Oana Sorop, Ilkka H A Heinonen, Joost J F P Luiken, Dunja Aksentijevic, Dirk J Duncker, Bryan C Dickinson, Sarah De Val, John R Ussher, William Fuller, Lisa C Heather
Förderung
- British Heart Foundation
- Wellcome Trust
- Dutch Research Council
Zitieren
APA
Dennis, K. M. J. H., Gopal, K., Montes Aparicio, C. N., Zhang, J. A., Castro-Guarda, M., Nicol, T., Devereux, R. M., Carter, R. D., Azizi, S. A., Lan, T., Purnama, U., Carr, C. A., Simsek, G., Gill, E. K., Swietach, P., Sorop, O., Heinonen, I. H. A., Schianchi, F., Luiken, J. J. F. P., …, & Heather, L. C. (2025). FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes. Circulation Research, 136(12), 1545-1560. https://doi.org/10.1161/circresaha.124.325918
Vancouver
Dennis KMJH, Gopal K, Montes Aparicio CN, Zhang JA, Castro-Guarda M, Nicol T, et al. FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes. Circulation Research. 2025;136(12):1545-1560. doi:10.1161/circresaha.124.325918
BibTeX
@article{Dennis2025,
author = {Dennis, Kaitlyn M J H and Gopal, Keshav and Montes Aparicio, Claudia N and Zhang, Jiashuo Aaron and Castro-Guarda, Marcos and Nicol, Thomas and Devereux, Ríona M and Carter, Ryan D and Azizi, Saara-Anne and Lan, Tong and Purnama, Ujang and Carr, Carolyn A and Simsek, Gul and Gill, Eleanor K and Swietach, Pawel and Sorop, Oana and Heinonen, Ilkka H A and Schianchi, Francesco and Luiken, Joost J F P and Aksentijevic, Dunja and Duncker, Dirk J and Dickinson, Bryan C and De Val, Sarah and Ussher, John R and Fuller, William and Heather, Lisa C},
title = {FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes},
journal = {Circulation Research},
year = {2025},
volume = {136},
number = {12},
pages = {1545--1560},
doi = {10.1161/circresaha.124.325918}
}
EUVIMED